Skip to main content
Amphastar Pharmaceuticals, Inc. (FRA:29A)
Germany flag Germany · Delayed Price · Currency is EUR
22.79
-0.40 (-1.72%)
At close: Dec 5, 2025

Amphastar Pharmaceuticals Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
1,0571,7242,6811,267980781
Upgrade
Market Cap Growth
-46.61%-35.67%111.55%29.32%25.47%-3.21%
Upgrade
Enterprise Value
1,3852,0913,0181,192972792
Upgrade
Last Close Price
22.7935.6556.0026.2020.2016.30
Upgrade
PE Ratio
11.1111.1921.5414.8217.94680.90
Upgrade
PS Ratio
1.722.444.602.712.552.73
Upgrade
PB Ratio
1.602.444.632.562.502.13
Upgrade
P/TBV Ratio
6.0712.60113.422.762.742.64
Upgrade
P/FCF Ratio
10.9510.3620.3920.7915.8040.81
Upgrade
P/OCF Ratio
8.158.3716.1515.1911.3716.68
Upgrade
EV/Sales Ratio
2.232.965.182.552.532.77
Upgrade
EV/EBITDA Ratio
6.828.3814.039.6311.6527.85
Upgrade
EV/EBIT Ratio
9.3110.5416.7011.8515.4373.07
Upgrade
EV/FCF Ratio
14.3412.5622.9519.5515.6841.37
Upgrade
Debt / Equity Ratio
0.850.890.980.190.240.15
Upgrade
Debt / EBITDA Ratio
3.082.462.560.751.051.69
Upgrade
Debt / FCF Ratio
5.803.784.291.581.482.87
Upgrade
Asset Turnover
0.450.470.570.710.670.57
Upgrade
Inventory Turnover
2.322.762.782.552.511.99
Upgrade
Quick Ratio
2.072.111.652.792.081.53
Upgrade
Current Ratio
3.123.072.173.993.062.49
Upgrade
Return on Equity (ROE)
14.84%23.26%23.55%18.76%14.16%0.25%
Upgrade
Return on Assets (ROA)
5.84%8.31%11.07%9.51%6.88%1.36%
Upgrade
Return on Capital (ROIC)
6.71%9.71%13.18%11.37%8.40%1.64%
Upgrade
Return on Capital Employed (ROCE)
10.30%14.60%15.50%16.60%12.60%2.60%
Upgrade
Earnings Yield
9.00%8.94%4.64%6.75%5.57%0.15%
Upgrade
FCF Yield
9.13%9.65%4.91%4.81%6.33%2.45%
Upgrade
Buyback Yield / Dilution
6.16%1.78%-1.09%-5.31%-1.34%1.57%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.